Mouse Anti-B3GAT3 Recombinant Antibody (1C11) (CBMAB-A0685-LY)

Name: Mouse Anti-B3GAT3 Recombinant Antibody (1C11)
SKU: CBMAB-A0685-LY
Rating: 5 (1 reviews)

See all B3GAT3 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

1C11

Application

WB, ELISA

Immunogen

B3GAT3 (NP_036332, 236 a.a. ~ 335 a.a) partial recombinant protein with GST tag.

Specificity

Human

Antibody Isotype

IgG2a, κ

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

PBS, pH 7.4

Preservative

None

Concentration

Batch dependent

Purity

> 95% Purity determined by SDS-PAGE.

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)

Introduction

The protein encoded by this gene is a member of the glucuronyltransferase gene family, enzymes that exhibit strict acceptor specificity, recognizing nonreducing terminal sugars and their anomeric linkages. This gene product catalyzes the formation of the glycosaminoglycan-protein linkage by way of a glucuronyl transfer reaction in the final step of the biosynthesis of the linkage region of proteoglycans. [provided by RefSeq]

Entrez Gene ID

26229

UniProt ID

O94766

Alternative Names

GLCATI; GlcAT-I

Function

Glycosaminoglycans biosynthesis (PubMed:25893793).
Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-glucuronic acid (UDP-GlcUA) to the common linkage region trisaccharide Gal-beta-1,3-Gal-beta-1,4-Xyl covalently bound to a Ser residue at the glycosaminylglycan attachment site of proteoglycans. Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins. Shows strict specificity for Gal-beta-1,3-Gal-beta-1,4-Xyl, exhibiting negligible incorporation into other galactoside substrates including Galbeta1-3Gal beta1-O-benzyl, Galbeta1-4GlcNAc and Galbeta1-4Glc. Stimulates 2-phosphoxylose phosphatase activity of PXYLP1 in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA) during completion of linkage region formation (PubMed:24425863).

Biological Process

Carbohydrate metabolic process Source: GO_Central
Chondroitin sulfate proteoglycan biosynthetic process Source: MGI
Dermatan sulfate proteoglycan biosynthetic process Source: MGI
Glycosaminoglycan biosynthetic process Source: UniProtKB
Glycosaminoglycan metabolic process Source: Reactome
Heparan sulfate proteoglycan biosynthetic process Source: MGI
Positive regulation of catalytic activity Source: UniProtKB
Positive regulation of intracellular protein transport Source: UniProtKB
Protein glycosylation Source: UniProtKB-UniPathway

Cellular Location

Golgi apparatus membrane; Cis-Golgi network

Involvement in disease

Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects (JDSCD): An autosomal recessive disease characterized by dysmorphic facies, bilateral dislocations of the elbows, hips, and knees, clubfeet, and short stature, as well as cardiovascular defects.

Topology

Cytoplasmic: 1-7 aa
Helical: 8-28 aa
Lumenal: 29-335 aa

PTM

N-glycosylated.

Colman, M., Van Damme, T., Steichen-Gersdorf, E., Laccone, F., Nampoothiri, S., Syx, D., ... & Malfait, F. (2019). The clinical and mutational spectrum of B3GAT3 linkeropathy: two case reports and literature review. Orphanet journal of rare diseases, 14(1), 1-10.

Yauy, K., Mau-Them, F. T., Willems, M., Coubes, C., Blanchet, P., Herlin, C., ... & Genevieve, D. (2018). B3GAT3-related disorder with craniosynostosis and bone fragility due to a unique mutation. Genetics in Medicine, 20(2), 269-274.

Bloor, S., Giri, D., Didi, M., & Senniappan, S. (2017). Novel splicing mutation in B3GAT3 associated with short stature, GH deficiency, Hypoglycaemia, developmental delay, and multiple congenital anomalies. Case reports in genetics, 2017.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-B3GAT3 Recombinant Antibody (1C11)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-B3GAT3 Recombinant Antibody (CBYY-0080) (CAT#: CBMAB-0080-YY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry